《广州医药》
点击关注官方服务号追踪稿件状态

【重要服务提醒】《广州医药》杂志服务号已上线稿件查询功能

各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。

操作方式

微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。

《广州医药》编辑部

广州医药杂志服务号
论著

雷火灸治疗小儿下元虚寒型遗尿症30例

30 cases of kidney deficiency-cold syndrome enuresis children by thunder-fire moxibustion

:75-78
 
目的 探讨雷火灸对于小儿下元虚寒型遗尿症的临床疗效。方法 采用回顾性分析,将60例遗尿症患儿随机分为治疗组和对照组各30例,对照组给予基础治疗(包括调整作息饮食、膀胱功能锻炼、反射训练等),治疗组则在基础治疗外给予雷火灸温灸小腹部及温阳补肾的相应穴位,两组均连续治疗3周。比较两组治疗前后每周遗尿天数、每天遗尿次数、每天的睡眠深度及中医症候积分变化,观察两组临床疗效及6个月后的复发率。结果 治疗组使用雷火灸治疗小儿遗尿症的总有效率96.67%高于对照组的总有效率76.67%,治疗组中医症候积分减少优于对照组,治疗后6个月治疗组的复发率为10.34%,少于对照组,差异均有统计学意义(P<0.05)。结论 雷火灸能有效减少下元虚寒型遗尿症患儿的遗尿次数,疗效显著,值得临床推广应用。
Objective To investigate the clinical efficacy of treating kidney deficiency-cold syndrome enuresis children with thunder-fire moxibustion. Methods 60 cases were randomly divided into a control group of 30 cases and a treatment group of 30 cases. Patients in the control group were treated with basic treatment (including adjusting diet, bladder function exercise, reflex training and so on); while patients in the treatment group were treated with thunder-fire moxibustion,three weeks for treatment. The research was aimed at assessing the clinical effect of the two groups,observing the number of enuresis days per week, the number of enuresis times per day,the sleep depth per day and the change of TCM symptom score, and recording the recurrence rate after 6 months of treatment. Results The clinical efficacy of treatment group was better than that of the control group,and the efficiency was 96.67%,which was higher than that of the control group 76.67%,and the TCM symptom score of the treatment group decreased than that of the control group, both of the differences were statistically significant (P< 0.05). The recurrence rates at 6 months after treatment was 10.34% respectively,which were lower than those in the control group(P<0.05). Conclusion The therapy has good effect,it can reduce the number of enuresis times and has low recurrence.
出版者信息








《广州医药》公众号